Measuring patient preferences for the treatment of rectal cancer

Quantifying and implementing patient preferences for the treatment of high-risk rectal cancer, including the new strategy of organ preservation: The PrefCoRe Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN17870623

Enrollment

600

Registered

2020-10-30

Start date

2020-11-04

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer Cancer Malignant neoplasm of rectum

Interventions

An online survey comprising a discrete choice experiment (DCE) will be designed to elicit preferences of a sample of patients and members of the public for the treatment of high-risk rectal cancer. Th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age 18+ years 2. Previous diagnosis of rectal cancer (for ~50% of participants) 3. Able to complete and submit an online DCE

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
Participant treatment preference recorded during the DCE at a single timepoint	—

Secondary

Measure	Time frame
Usability score recorded for the designed Dynamic Computer Interactive Decision Application (DCIDA) measured using the System Usability Scale (SUS) at a single timepoint immediately after the intervention	—

Countries

England, United Kingdom

Contacts

Public ContactLee Malcomson

lee.malcomson@manchester.ac.uk+44 (0)1614468417

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026